Outside of its pain-relieving outcomes, conolidine has demonstrated a positive basic safety margin in preclinical toxicology assessments. Not like opioids, which regularly result in respiratory depression at increased doses, conolidine hasn't produced signs of significant respiratory suppression. Moreover, behavioral assessments in murine designs c… Read More